These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 11360741

  • 1. [Acceptability and tolerance of prednisolone metasulfobenzoate in orally dispersing tablet].
    Delmas PD, Olivieri-Apicella N, Coriat F.
    Presse Med; 2001 Apr 21; 30(15):738-9. PubMed ID: 11360741
    [No Abstract] [Full Text] [Related]

  • 2. [Acceptability and tolerance of prednisolone metasulfobenzoate in orally dispersing tablets in 2 to 12-years-old children].
    Rancé F, Deslandes B, Decosta P.
    Arch Pediatr; 2004 Sep 21; 11(9):1127-30. PubMed ID: 15351007
    [No Abstract] [Full Text] [Related]

  • 3. COLAL-PRED Alizyme.
    Hanauer SB, Sparrow M.
    Curr Opin Investig Drugs; 2004 Nov 21; 5(11):1192-7. PubMed ID: 15573870
    [Abstract] [Full Text] [Related]

  • 4. [Comparative bioavailability of prednisolone metasulfobenzoate with prednisolone].
    Flouvat B, Molinier P, Dellatolas F.
    Therapie; 1994 Nov 21; 49(1):53-4. PubMed ID: 8091369
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetic parameters of prednisone and prednisolone in healthy volunteers].
    Etienne SD, Vandermeersch V, Chosidow O, Vu-Thi-My-Le C, Godeau P, Diquet B, Herson S.
    Ann Med Interne (Paris); 1990 Nov 21; 141(6):507-11. PubMed ID: 2285202
    [Abstract] [Full Text] [Related]

  • 6. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing.
    Skowyra J, Pietrzak K, Alhnan MA.
    Eur J Pharm Sci; 2015 Feb 20; 68():11-7. PubMed ID: 25460545
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacokinetics and tolerance of an orally administered combination preparation containing phenylbutazone and prednisolone in the dog].
    Kietzmann M, Meyer-Lindenberg A, Engelke A, Nolte I.
    Dtsch Tierarztl Wochenschr; 1996 Jan 20; 103(1):14-6. PubMed ID: 8647008
    [Abstract] [Full Text] [Related]

  • 8. Tablet splitting and weight uniformity of half-tablets of 4 medications in pharmacy practice.
    Tahaineh LM, Gharaibeh SF.
    J Pharm Pract; 2012 Aug 20; 25(4):471-6. PubMed ID: 22544621
    [Abstract] [Full Text] [Related]

  • 9. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
    Dowson AJ, Charlesworth BR.
    Int J Clin Pract; 2003 Sep 20; 57(7):573-6. PubMed ID: 14529055
    [Abstract] [Full Text] [Related]

  • 10. Part III: the convenience of, and patient preference for, zolmitriptan orally disintegrating tablet.
    Dowson AJ, Almqvist P.
    Curr Med Res Opin; 2005 Sep 20; 21 Suppl 3():S13-7. PubMed ID: 16083519
    [Abstract] [Full Text] [Related]

  • 11. Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncology.
    Abernethy AP, Herndon JE, Wheeler JL, Day JM, Hood L, Patwardhan M, Shaw H, Lyerly HK.
    J Pain Symptom Manage; 2009 Jun 20; 37(6):1027-38. PubMed ID: 19394793
    [Abstract] [Full Text] [Related]

  • 12. [Intra-cavity injection of prednisolone in the treatment of bone cyst].
    Hu YG.
    Zhonghua Wai Ke Za Zhi; 1986 Feb 20; 24(2):119-20, 127. PubMed ID: 3743264
    [No Abstract] [Full Text] [Related]

  • 13. Bioequivalence of different prednisolone tablet formulations.
    Luippold G, Benöhr P, Schneider S, Marto M, Mühlbauer B.
    Arzneimittelforschung; 2001 Feb 20; 51(8):638-42. PubMed ID: 11556124
    [Abstract] [Full Text] [Related]

  • 14. A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe.
    Gremse DA, Donnelly JR, Kukulka MJ, Lloyd E, Lee C.
    Aliment Pharmacol Ther; 2004 Jun 01; 19(11):1211-5. PubMed ID: 15153174
    [Abstract] [Full Text] [Related]

  • 15. [Effect of intra-articular injection of prednisolone in treating organic destruction in the TMJ syndrome].
    Zhang X.
    Zhonghua Kou Qiang Ke Za Zhi; 1985 Mar 01; 20(2):93-5, 127. PubMed ID: 3860363
    [No Abstract] [Full Text] [Related]

  • 16. Quantitative determination of captopril and prednisolone in tablets by FT-Raman spectroscopy.
    Mazurek S, Szostak R.
    J Pharm Biomed Anal; 2006 Mar 18; 40(5):1225-30. PubMed ID: 16253463
    [Abstract] [Full Text] [Related]

  • 17. [Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: a comparative multicenter study].
    Dreno B, Sassolas B, Lacour P, Montpoint S, Lota I, Giordano F, Royer P.
    Ann Dermatol Venereol; 1993 Mar 18; 120(8):518-21. PubMed ID: 8304707
    [Abstract] [Full Text] [Related]

  • 18. [Corticosteroid prevention of hyaline membrane disease].
    Tiufekchieva E, Tomanov V.
    Akush Ginekol (Sofiia); 1984 Mar 18; 23(3):225-33. PubMed ID: 6236707
    [No Abstract] [Full Text] [Related]

  • 19. [Dermatomyocoses and their treatment with cortizonoid-containing drugs].
    Fadrhoncová A, Bílek J.
    Cesk Dermatol; 1982 Jun 18; 57(3):175-6. PubMed ID: 6214327
    [No Abstract] [Full Text] [Related]

  • 20. Randomized controlled trial of sodium phosphate tablets vs polyethylene glycol solution for colonoscopy bowel cleansing.
    Jung YS, Lee CK, Kim HJ, Eun CS, Han DS, Park DI.
    World J Gastroenterol; 2014 Nov 14; 20(42):15845-51. PubMed ID: 25400471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.